Surface Logix, Inc. Receives $20,000,000 New Round

  • Feed Type
  • Date
    3/9/2009
  • Company Name
    Surface Logix, Inc.
  • Mailing Address
    50 Soldiers Field Place Brighton, MA 02135
  • Company Description
    Surface Logix is a drug development company which uses its expertise in biophysical chemistry to create new small molecule drugs with significantly improved pharmacokinetic (PK) and pharmacodynamic (PD) properties compared with class leaders.
  • Website
    http://www.surfacelogix.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Surface Logix Inc. uses its expertise in biophysical chemistry to create and develop novel small molecule drugs to treat metabolic and cardiovascular disease. For more information
  • M&A Terms
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    HBM Bioventures
  • Venture Investor
    HealthCare Ventures
  • Venture Investor
    Intel Capital
  • Venture Investor
    Venrock
  • Venture Investor
    Unilever
  • Venture Investor
    MPM Capital

Trending on Xconomy